LRP1 and early-onset autosomal dominant Alzheimer disease: Up-regulation of LRP-1 has been reported in numerous human diseases including Alzheimer disease [28,29], breast cancer [30], prostate cancer [31], multiple sclerosis [32], proliferative retinopathy [33], and ischemic cardiomyopathy [34].